<< Back to News

System Formulary Update
Risperidone (Uzedy) subcutaneous injection
January 27, 2025

Situation: Risperidone (Uzedy) was approved for addition to the UNC Health System Formulary at the System Pharmacy and Therapeutics Committee meeting.

Background: The following medications were reviewed: Risperidone extended-release subcutaneous injection

• 50 mg/0.14 mL single-dose prefilled syringe
• 75 mg/0.21 mL single-dose prefilled syringe
• 100 mg/0.28 mL single-dose prefilled syringe
• 125 mg/0.35 mL single-dose prefilled syringe
• 150 mg/0.42 mL single-dose prefilled syringe 

Assessment/Recommendation: System P&T voted to include the following products on the UNC Health Medication Formulary:

• Risperidone (Uzedy) extended-release subcutaneous injection

Note: Stock of this formulary product may vary at individual entities 

Formulary/Epic Changes will Go-Live on Tuesday, March 11^th